$6.710
-0.517 (-7.70%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CAPR por análisis de gráficos similares
Alphio's CAPR stock price prediction model matches the current Capricor Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.76 (+0.76%). The 1-week path is $6.59 (-1.82%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Capricor Therapeutics, Inc.?
Capricor Therapeutics Inc is not a good buy right now due to its current price of $6.71, which is significantly below the analyst price target of $21 from B. Riley, indicating potential upside. However, the stock has a very low RSI of 32.184, suggesting it is oversold, but the negative sentiment surrounding the FDA review delay and a projected 8% drop in stock price makes it risky. The main risk is the company's ongoing losses, with a net income of -40,733,654 USD for Q2 2026, which raises concerns about its financial health.
CAPR cerró en $6.71 el Friday, tras bajar -7.70%
Capricor Therapeutics, Inc. (CAPR) last closed at $6.71, losing -7.70%. These facts feed the 1-day and 1-week CAPR price prediction above.
Consenso de analistas
Capricor Therapeutics, Inc. (CAPR): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Capricor Therapeutics, Inc. (CAPR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CAPR, ordenadas por similitud.
Análisis de estacionalidad de CAPR
Historically the probability of a positive October return for CAPR is 39.66%. December offers the highest probability of a positive month at 95.35%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CAPR
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $8.24 | $12.21 | $16.03 | +82.03% |
| Nov 2026 | $12.48 | $12.69 | $16.52 | +89.13% |
| Dec 2026 | $12.37 | $13.41 | $14.03 | +99.82% |
En 2026, se proyecta que Capricor Therapeutics, Inc. (CAPR) oscile entre $8.24 y $16.52.
Previsión mensual de Capricor Therapeutics, Inc. para 2026
En Oct de 2026, se proyecta que Capricor Therapeutics, Inc. promedie $12.21, con un mínimo de $8.24 y un máximo de $16.03.
En Nov de 2026, se proyecta que Capricor Therapeutics, Inc. promedie $12.69, con un mínimo de $12.48 y un máximo de $16.52.
En Dec de 2026, se proyecta que Capricor Therapeutics, Inc. promedie $13.41, con un mínimo de $12.37 y un máximo de $14.03.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.